Drug:
Reaction: ASTHMA
20250101 - 20251231
No. 501 - 600
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 501 | 25080174 |
CA |
66 | |
Asthma, Blood immunoglobulin E increased, COVID-19, Drug ineffective, Dry throat, Dyspepsia, Dysphonia, Eosinophil count increased, Eructation, Glaucoma, Mean cell volume increased, Middle insomnia, Nasal congestion, Obstructive airways disorder, Product dose omission issue, Red blood cell sedimentation rate increased, Renal impairment, Rhinitis, Rhinitis allergic, Rhinorrhoea, Throat clearing, Total lung capacity decreased, Upper-airway cough syndrome, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, TELMISARTAN, ALBUTEROL SULFATE, |
||||
| 502 | 25080220 |
DE |
55 | 2 |
Septic shock, Large intestine perforation, Anterior segment ischaemia, Peritonitis, Overdose, Product prescribing issue, Asthma, |
||||
| 503 | 25080231 |
CA |
57 | 2 |
Hypertension, Blood pressure increased, Ageusia, Anosmia, Asthma, Oxygen saturation decreased, Productive cough, White coat hypertension, Pneumonia, Malaise, Fatigue, |
||||
TIOTROPIUM BROMIDE, BUDESONIDE, ALBUTEROL SULFATE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, MONTELUKAST SODIUM, MONTELUKAST, MONTELUKAST SODIUM, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, |
||||
| 504 | 25071601 |
US |
2 | |
Asthma, Drug delivery system issue, |
||||
ALBUTEROL SULFATE, |
||||
| 505 | 25071655 |
US |
||
Asthma, Product use issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 506 | 25071682 |
MY |
41 | 1 |
Asthma, Anosmia, Upper-airway cough syndrome, Poor quality sleep, Drug ineffective, |
||||
OMALIZUMAB, |
||||
| 507 | 25071690 |
US |
2 | |
Atrial fibrillation, Oesophageal disorder, Asthma, |
||||
ADALIMUMAB, |
||||
| 508 | 25071768 |
CA |
49 | 1 |
Aphonia, Arthralgia, Asthma, Back pain, Blood pressure systolic increased, Cough, Dyspnoea, Forced expiratory volume decreased, General physical health deterioration, Haemoptysis, Headache, Heat exhaustion, Middle insomnia, Muscle spasms, Nodule, Oropharyngeal pain, Pain in extremity, Pneumonia bacterial, |
||||
OMALIZUMAB, OMALIZUMAB, TADALAFIL, DICLOFENAC, DICLOFENAC SODIUM, DUPILUMAB, DUTASTERIDE, OXYCODONE, PREGABALIN, ALBUTEROL SULFATE, ALBUTEROL, SILODOSIN, MONTELUKAST SODIUM, TIOTROPIUM BROMIDE, TESTOSTERONE, TESTOSTERONE,, ELUXADOLINE, |
||||
| 509 | 25071786 |
US |
68 | 2 |
Asthma, Influenza, |
||||
DUPILUMAB, |
||||
| 510 | 25071793 |
US |
33 | 1 |
Asthma, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 511 | 25071853 |
US |
32 | 1 |
Asthma, Influenza, Dyspnoea, |
||||
DUPILUMAB, |
||||
| 512 | 25071872 |
CA |
79 | 1 |
Arthralgia, Asthma, Condition aggravated, Confusional state, Cough, Dyspnoea, Fall, Forced expiratory volume abnormal, Incorrect dose administered, Limb injury, Middle insomnia, Weight increased, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, TIOTROPIUM BROMIDE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, |
||||
| 513 | 25071950 |
US |
76 | 2 |
Wheezing, Asthma, |
||||
DUPILUMAB, |
||||
| 514 | 25072078 |
US |
37 | 2 |
Food allergy, Allergy to animal, Balance disorder, Dizziness, Asthma, Drug hypersensitivity, |
||||
DUPILUMAB, |
||||
| 515 | 25072084 |
US |
||
Nasopharyngitis, Asthma, Asthenia, |
||||
BENRALIZUMAB, ALBUTEROL SULFATE, ALBUTEROL, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, GABAPENTIN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, MONTELUKAST, |
||||
| 516 | 25072099 |
US |
34 | 1 |
Asthma, |
||||
DUPILUMAB, |
||||
| 517 | 25072162 |
GB |
70 | 2 |
Bronchospasm, Asthma, |
||||
NAPROXEN, NAPROXEN SODIUM, MONTELUKAST, SOLIFENACIN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, TOPIRAMATE, TOPIRAMATE SPINKLE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, SUMATRIPTAN, SUMATRIPTAN SUCCINATE, |
||||
| 518 | 25072270 |
US |
50 | 2 |
Asthma, Dyspnoea, |
||||
DUPILUMAB, |
||||
| 519 | 25072354 |
CA |
61 | 2 |
Sinusitis, Asthma, Blood pressure increased, Bronchitis, Contusion, Cough, Dyspnoea, Dyspnoea exertional, Fall, Gait disturbance, Illness, Influenza, Injection site erythema, Injection site pain, Injection site pruritus, Injection site swelling, Limb injury, Malaise, Nasopharyngitis, Oxygen saturation decreased, Pain in extremity, Pneumonia, Pulmonary congestion, Rhinitis, Scratch, Seasonal allergy, Speech disorder, Viral infection, Wheezing, Product availability issue, Wrong technique in product usage process, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, CICLESONIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, DESOXIMETASONE, MOXIFLOXACIN HYDROCHLORIDE, OLOPATADINE HYDROCHLORIDE, OLOPATADINE HYDROCHLORIDE OPHTHALMIC, ALBUTEROL SULFATE, ALBUTEROL, GLYCOPYRROLATE, MONTELUKAST SODIUM, TIOTROPIUM BROMIDE, TOBRAMYCIN, TOBRAMYCIN SULFATE, TOBRAMYCIN SOLUTION, ALBUTEROL SULFATE, |
||||
| 520 | 25072401 |
US |
2 | |
Influenza, Bronchitis, Asthma, Dyspnoea, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 521 | 25072528 |
US |
66 | 2 |
Asthma, Drug ineffective, |
||||
MEPOLIZUMAB, FLUTICASONE PROPIONATE AND SALMETEROL, MONTELUKAST SODIUM, LOSARTAN, ATORVASTATIN CALCIUM, |
||||
| 522 | 25072548 |
CA |
47 | 1 |
Asthma, Blood pressure systolic increased, Carpal tunnel syndrome, Drug ineffective, Dyspnoea, Dyspnoea exertional, Ear infection, Fatigue, Food poisoning, Gastroenteritis, Heart rate increased, Hypersensitivity, Influenza, Insomnia, Malaise, Pain, Product dose omission issue, Productive cough, Secretion discharge, Sinusitis, Wheezing, Weight increased, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, MONTELUKAST SODIUM, |
||||
| 523 | 25072591 |
US |
86 | 1 |
Impaired quality of life, Asthma, |
||||
DUPILUMAB, |
||||
| 524 | 25072785 |
US |
16 | 1 |
Treatment failure, Asthma, |
||||
ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 525 | 25073169 |
JP |
||
Asthma, |
||||
MEPOLIZUMAB, |
||||
| 526 | 25073388 |
CA |
||
Asthenia, Blood cholesterol increased, Decreased appetite, Injury, Mobility decreased, Off label use, Prescribed underdose, Sciatica, Anti-cyclic citrullinated peptide antibody positive, Asthma, Chest pain, Gait inability, Lower limb fracture, Nausea, Road traffic accident, Urticaria, |
||||
CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, PREDNISONE, PREDNISONE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, CALCIUM CARBONATE, ANTACID, CALCIUM CARBONATE, ANTACID, CALCIUM CARBONATE, ANTACID, CELECOXIB, CERTOLIZUMAB PEGOL, CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DOXYCYCLINE, DOXYCYCLINE HYCLATE, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, GOLIMUMAB, GOLIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, SARILUMAB, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, APREMILAST, OXYCODONE, HYDROXYCHLOROQUINE SULFATE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, INFLIXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOFACITINIB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, VITAMIN C, ERGOCALCIFEROL, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, PREDNISONE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, |
||||
| 527 | 25073390 |
US |
||
Asthma, |
||||
MEPOLIZUMAB, |
||||
| 528 | 25073499 |
US |
2 | |
Asthma, Rebound effect, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 529 | 25073817 |
US |
68 | 1 |
Gout, Dry mouth, Product use in unapproved indication, Tremor, Disturbance in attention, Dyspnoea, Depression, Dyskinesia, Fatigue, Gait disturbance, Product dose omission issue, Dizziness, Asthma, Hypertension, Feeling abnormal, Initial insomnia, Musculoskeletal stiffness, Balance disorder, |
||||
DEUTETRABENAZINE, DEUTETRABENAZINE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ALBUTEROL SULFATE, BACLOFEN, LORATADINE, LORATADINE TABLET, FLUTICASONE PROPIONATE, TRIPROLIDINE HCL, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, FLUOROMETHOLONE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, TEZEPELUMAB-EKKO, FAMOTIDINE, LOSARTAN POTASSIUM, LOSARTAN, MONTELUKAST, DEUTETRABENAZINE, PREDNISONE, HYDROCHLOROTHIAZIDE, ERGOCALCIFEROL, |
||||
| 530 | 25073966 |
CA |
53 | 2 |
Asthenia, Asthma, Bladder pain, Blood pressure fluctuation, Blood pressure increased, Blood thyroid stimulating hormone increased, Bronchitis, Cataract, Concussion, Condition aggravated, Cough, Dizziness, Dyspnoea, Ear discomfort, Eye pruritus, Fall, Fatigue, Feeling hot, Gait disturbance, Gastroenteritis, Head banging, Headache, Hypersensitivity, Hypertension, Inappropriate schedule of product administration, Influenza, Lymphadenitis, Lymphadenopathy, Migraine, Mood altered, Nasal pruritus, Nasopharyngitis, Neck pain, Oral pruritus, Paraesthesia, Pneumonitis, Pruritus, Respiratory disorder, Respiratory syncytial virus infection, Respiratory tract congestion, Retinal tear, Salivary hypersecretion, Sensitivity to weather change, Sinusitis, Sneezing, Somnolence, Stress, Swelling, Swelling face, Throat irritation, Thyroid mass, Wound infection fungal, Wrong technique in product usage process, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, CICLESONIDE, DIPHENHYDRAMINE HYDROCHLORIDE, CANDESARTAN, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, TERBINAFINE HYDROCHLORIDE, MONTELUKAST SODIUM, TIOTROPIUM BROMIDE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, |
||||
| 531 | 25074101 |
CA |
||
Condition aggravated, Exposure during pregnancy, Anxiety, Bursitis, Maternal exposure during pregnancy, Asthma, Adjustment disorder with depressed mood, Abdominal pain upper, Blister, C-reactive protein abnormal, Amnesia, Contusion, Autoimmune disorder, Anti-cyclic citrullinated peptide antibody positive, Arthropathy, Blood cholesterol increased, Abdominal discomfort, Breast cancer stage III, Arthralgia, Abdominal pain, Alopecia, Asthenia, Medication error, Off label use, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, PREDNISONE, PREDNISONE, APREMILAST, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, BENZOCAINE, TOPICAL ANESTHETIC, CELECOXIB, CELECOXIB, CERTOLIZUMAB PEGOL, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, CORTISONE ACETATE, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DOXYCYCLINE, DOXYCYCLINE HYCLATE, ETANERCEPT, ETANERCEPT, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, GOLIMUMAB, GOLIMUMAB, ADALIMUMAB, ADALIMUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE ACETATE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, ADALIMUMAB-ADAZ, INFLIXIMAB, INFLIXIMAB, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, LEFLUNOMIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, APREMILAST, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, INFLIXIMAB, INFLIXIMAB, RISEDRONATE SODIUM, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOCILIZUMAB, USTEKINUMAB, VITAMIN C, PREDNISONE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, CAFFEINE CITRATE, CAFFEINE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 532 | 25074237 |
CA |
74 | 2 |
Diabetes mellitus, Asthmatic crisis, Weight decreased, Wheezing, Arthralgia, Stress, Blood pressure systolic increased, Cough, Sensitivity to weather change, Illness, Respiratory rate increased, Injection site scab, Peripheral swelling, Productive cough, Injection site erythema, Hypersensitivity, Asthma, Wrong technique in product usage process, Drug ineffective, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, VALSARTAN, VALSARTAN, VALSARTAN, VALSARTAN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FLUTICASONE FUROATE, FLUTICASONE FUROATE, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, MONTELUKAST SODIUM, MONTELUKAST SODIUM, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, |
||||
| 533 | 25074662 |
US |
43 | 2 |
Sleep disorder, Asthma, |
||||
DUPILUMAB, DUPILUMAB, OBETICHOLIC ACID, |
||||
| 534 | 25074716 |
FR |
1 | |
Respiratory syncytial virus test positive, Asthma, Drug ineffective, |
||||
NIRSEVIMAB, |
||||
| 535 | 25074833 |
CA |
76 | 2 |
Blood pressure increased, Cholelithiasis, Malaise, Urinary tract infection, Alopecia, Blood pressure decreased, Cough, Inappropriate schedule of product administration, Asthma, Fatigue, Dizziness, Sleep disorder due to a general medical condition, |
||||
AMLODIPINE, MEPOLIZUMAB, RAMIPRIL, CICLESONIDE, ALBUTEROL SULFATE, CICLESONIDE, RAMIPRIL, RAMIPRIL, |
||||
| 536 | 25074834 |
CA |
65 | 2 |
Wheezing, Asthma, Drug hypersensitivity, Vomiting, Oedema, Dyspnoea, Pneumonia, |
||||
AMLODIPINE, AMINOPHYLLINE, CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE, CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN, CLONAZEPAM, ROSUVASTATIN, HYDROMORPHONE HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE, OMALIZUMAB, PREDNISOLONE SODIUM PHOSPHATE, RISEDRONATE SODIUM, RITUXIMAB, ROPIVACAINE HYDROCHLORIDE, MONTELUKAST SODIUM, TRAMADOL HYDROCHLORIDE, |
||||
| 537 | 25074866 |
TR |
||
Bronchospasm, Asthma, |
||||
PALOPEGTERIPARATIDE, |
||||
| 538 | 25075160 |
2 | ||
Asthma, Quality of life decreased, |
||||
TEZEPELUMAB-EKKO, |
||||
| 539 | 25075196 |
BR |
||
Respiratory failure, Pneumonia, Asthma, Herpes zoster, |
||||
MEPOLIZUMAB, |
||||
| 540 | 25075882 |
US |
70 | |
Asthma, Cough, Upper-airway cough syndrome, Overweight, Wheezing, Productive cough, Obstructive airways disorder, Sleep apnoea syndrome, Dyspnoea, Snoring, Insomnia, Ehlers-Danlos syndrome, Hypertension, Gout, Hyperlipidaemia, Back pain, Coronary artery disease, Generalised anxiety disorder, Diverticulum intestinal, Parathyroid hormone-related protein, Prostatitis, Steatohepatitis, Bronchial secretion retention, Acquired ATTR amyloidosis, Nausea, Eosinophil count, Eosinopenia, Emphysema, Pneumonitis, Symptom recurrence, Albumin urine present, |
||||
ALBUTEROL SULFATE, ALBUTEROL, AMLODIPINE, METHOCARBAMOL, FLUTICASONE PROPIONATE, TRIPROLIDINE HCL, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, HYDRALAZINE HYDROCHLORIDE, LOSARTAN, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, SUMATRIPTAN, SUMATRIPTAN SUCCINATE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, |
||||
| 541 | 25076211 |
US |
58 | 2 |
Gingival recession, Asthma, Bowel movement irregularity, Shoulder operation, Diarrhoea, Joint swelling, Peripheral swelling, Pruritus, |
||||
POLYETHYLENE GLYCOL 3350, OBETICHOLIC ACID, URSODIOL, URSOSIOL, ACETAMINOPHEN AND CODEINE, ERENUMAB-AOOE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES, FISH OIL, LEVOTHYROXINE, LISINOPRIL, RIZATRIPTAN BENZOATE, NORTRIPTYLINE HYDROCHLORIDE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, TIZANIDINE HYDROCHLORIDE, TOPIRAMATE, TOPIRAMATE SPINKLE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, |
||||
| 542 | 25076463 |
CA |
34 | 2 |
Nasal oedema, Oedema, Drug hypersensitivity, Asthma, Pneumonia, Chest pain, Malaise, Pain, Vomiting, |
||||
AMLODIPINE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, CALCIUM, CLONAZEPAM, ERGOCALCIFEROL, HYDROMORPHONE HYDROCHLORIDE, MONTELUKAST SODIUM, MONTELUKAST, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN, OMALIZUMAB, PREDNISONE, RISEDRONATE SODIUM, RITUXIMAB, ROSUVASTATIN, THEOPHYLLINE, TRAMADOL HYDROCHLORIDE, CEFADROXIL, NEOMYCIN OINTMENT, POLYMYXIN B SULFATE, |
||||
| 543 | 25078373 |
2 | ||
General symptom, Asthma, |
||||
OMALIZUMAB, BENRALIZUMAB, MONTELUKAST SODIUM, MONTELUKAST, PREDNISONE, |
||||
| 544 | 25066525 |
CA |
18 | 1 |
Asthma, Obstructive airways disorder, Dizziness, Forced expiratory flow decreased, Forced vital capacity decreased, Off label use, Sleep disorder, Weight decreased, Syncope, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, MONTELUKAST SODIUM, ALBUTEROL SULFATE, |
||||
| 545 | 25066898 |
CA |
65 | 2 |
Asthma, Chest pain, Cough, Drug hypersensitivity, Dyspnoea, Malaise, Nasal oedema, Oedema, Pain, Pneumonia, Respiratory tract infection, Vomiting, Wheezing, |
||||
RITUXIMAB, CLONAZEPAM, OMALIZUMAB, OMALIZUMAB, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, |
||||
| 546 | 25067320 |
CA |
||
Asthma, Pneumonia, Candida infection, Cough, Dysphonia, |
||||
MEPOLIZUMAB, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, ALBUTEROL SULFATE, TIOTROPIUM BROMIDE, |
||||
| 547 | 25067507 |
US |
2 | |
Anxiety, Dyspnoea, Asthma, |
||||
MEPOLIZUMAB, |
||||
| 548 | 25067743 |
US |
||
Asthma, Dyspnoea, |
||||
BENRALIZUMAB, |
||||
| 549 | 25067883 |
US |
2 | |
Rheumatoid arthritis, Pain, Arthralgia, Multiple sclerosis, Anxiety, Photosensitivity reaction, Rash, Swelling face, Decreased immune responsiveness, Asthma, |
||||
OFATUMUMAB, |
||||
| 550 | 25067893 |
CA |
2 | |
Helicobacter infection, Lower limb fracture, Lupus vulgaris, Sleep disorder, Eye injury, Headache, Blood cholesterol increased, Confusional state, Abdominal pain upper, Infusion related reaction, Therapeutic response decreased, Pain, Drug ineffective, Vomiting, Psoriatic arthropathy, Anxiety, Glossodynia, Lower respiratory tract infection, Irritable bowel syndrome, Condition aggravated, Product use issue, Rheumatoid arthritis, Leukopenia, Contraindicated product administered, Sleep disorder due to general medical condition, insomnia type, Pericarditis, Fatigue, General physical health deterioration, Dizziness, Folliculitis, Anti-cyclic citrullinated peptide antibody positive, Type 2 diabetes mellitus, Road traffic accident, Deep vein thrombosis postoperative, Stomatitis, Urticaria, Hand deformity, Injury, Discomfort, Alopecia, Ulcer haemorrhage, Drug hypersensitivity, Maternal exposure during pregnancy, Synovitis, Impaired healing, Hypertension, Prescribed overdose, Gastrointestinal disorder, Product use in unapproved indication, Diarrhoea, Rash pruritic, Pemphigus, Peripheral swelling, Nasopharyngitis, Muscle injury, Intentional product use issue, Pyrexia, Systemic lupus erythematosus, Weight increased, Sinusitis, Gait inability, Duodenal ulcer perforation, Asthma, Chest pain, Off label use, Swelling, Autoimmune disorder, Fibromyalgia, Drug intolerance, Liver disorder, |
||||
NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, HYDROXYCHLOROQUINE, TOFACITINIB, TOFACITINIB, OXYCODONE, LEFLUNOMIDE, ADALIMUMAB, ABATACEPT, ABATACEPT, TOCILIZUMAB, TOCILIZUMAB, ALENDRONATE SODIUM, PREDNISONE, PREDNISONE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CALCIUM GLUCONATE, INFLIXIMAB, INFLIXIMAB, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, LEFLUNOMIDE, CELECOXIB, CELECOXIB, CALCIUM CARBONATE, CALCIUM CHLORIDE INJECTION, CALCIUM CHLORIDE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, CERTOLIZUMAB PEGOL, VITAMIN C, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, USTEKINUMAB, MAGNESIUM, CAFFEINE, LORAZEPAM, ERGOCALCIFEROL, LORAZEPAM, LANSOPRAZOLE, LISINOPRIL, |
||||
| 551 | 25068139 |
US |
75 | 2 |
Asthma, Bronchitis, Hypersensitivity, Asthma, Cough, |
||||
TOFACITINIB, |
||||
| 552 | 25068338 |
US |
52 | 2 |
Eosinophilic oesophagitis, Upper-airway cough syndrome, Asthma, Cough, |
||||
DUPILUMAB, |
||||
| 553 | 25068361 |
US |
9 | 1 |
Nasopharyngitis, Asthma, Cough, |
||||
DUPILUMAB, |
||||
| 554 | 25068366 |
US |
85 | 2 |
Cough, Weight increased, Asthma, |
||||
DUPILUMAB, |
||||
| 555 | 25068392 |
US |
67 | 2 |
Asthma, |
||||
| 556 | 25068464 |
US |
74 | 2 |
Asthma, |
||||
DUPILUMAB, |
||||
| 557 | 25068473 |
US |
59 | 2 |
Asthma, Alopecia, Injection site pain, |
||||
DUPILUMAB, |
||||
| 558 | 25068563 |
US |
64 | 2 |
Stress, Asthma, |
||||
DUPILUMAB, |
||||
| 559 | 25068732 |
ZA |
5 | |
Asthma, Asthma, |
||||
MONTELUKAST SODIUM, MONTELUKAST, FLUTICASONE PROPIONATE, DESLORATADINE, |
||||
| 560 | 25068807 |
US |
76 | 2 |
Asthma, |
||||
DUPILUMAB, |
||||
| 561 | 25068868 |
US |
2 | |
Impaired quality of life, Asthma, |
||||
DUPILUMAB, |
||||
| 562 | 25068883 |
US |
1 | |
Asthma, |
||||
DUPILUMAB, |
||||
| 563 | 25068921 |
US |
49 | 2 |
Dry mouth, Vascular graft, Pruritus, Asthma, |
||||
DUPILUMAB, ALBUTEROL SULFATE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, MONTELUKAST, SERTRALINE HYDROCHLORIDE, SIMVASTATIN, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 564 | 25068924 |
US |
2 | |
Asthma, |
||||
DUPILUMAB, PREDNISONE, GABAPENTIN, DEXLANSOPRAZOLE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, ROSUVASTATIN CALCIUM, THYROID, PORCINE, MONTELUKAST SODIUM, MONTELUKAST, BIMATOPROST, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, MUPIROCIN, MUPIROCIN CALCIUM, |
||||
| 565 | 25068992 |
US |
11 | 1 |
Asthma, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 566 | 25069011 |
US |
57 | 2 |
Sinusitis, Bronchitis, Influenza, Asthma, |
||||
DUPILUMAB, |
||||
| 567 | 25069018 |
US |
43 | 1 |
Anosmia, Condition aggravated, Ageusia, Condition aggravated, Nasal polyps, Condition aggravated, Asthma, |
||||
DUPILUMAB, DUPILUMAB, MELATONIN, ALBUTEROL SULFATE, MONTELUKAST SODIUM, MONTELUKAST, FLUTICASONE PROPIONATE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, |
||||
| 568 | 25069028 |
US |
27 | 2 |
Eczema, Blister, Pruritus, Asthma, |
||||
DUPILUMAB, |
||||
| 569 | 25069054 |
US |
65 | 2 |
Asthma, Hypersensitivity, |
||||
DUPILUMAB, |
||||
| 570 | 25069069 |
US |
66 | 2 |
Asthma, Cough, |
||||
DUPILUMAB, |
||||
| 571 | 25069094 |
US |
71 | 2 |
Asthma, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 572 | 25069155 |
US |
60 | 2 |
Cough, Nasopharyngitis, Asthma, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 573 | 25069165 |
US |
18 | 2 |
Asthma, Impaired quality of life, |
||||
DUPILUMAB, DUPILUMAB, ALBUTEROL SULFATE AND BUDESONIDE, ALBUTEROL SULFATE, ALBUTEROL, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, SERTRALINE, TIOTROPIUM BROMIDE, ALBUTEROL SULFATE, |
||||
| 574 | 25069189 |
US |
2 | |
Asthma, Impaired quality of life, |
||||
DUPILUMAB, ALBUTEROL SULFATE AND BUDESONIDE, AMOXICILLIN AND CLAVULANATE POTASSIUM, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, DIPHENHYDRAMINE HYDROCHLORIDE, LORATADINE, LORATADINE TABLET, ESTRADIOL, FISH OIL, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LEVALBUTEROL, LEVALBUTEROL HYDROCHLORIDE, GUAIFENESIN, PREDNISONE, SERTRALINE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 575 | 25070266 |
TR |
||
Rheumatoid arthritis, Asthma, Cardiac disorder, Pain in extremity, |
||||
ECULIZUMAB, ECULIZUMAB, |
||||
| 576 | 25070447 |
US |
1 | |
Asthma, Cough, |
||||
DUPILUMAB, FLUTICASONE PROPIONATE, TIRZEPATIDE, RAMIPRIL, ROSUVASTATIN CALCIUM, NEBIVOLOL, NEBIVOLOL HYDROCHLORIDE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, PREDNISONE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LOTEPREDNOL ETABONATE, TESTOSTERONE CYPIONATE, MORPHINE SULFATE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 577 | 25070504 |
US |
40 | 2 |
Asthma, Illness, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 578 | 25070506 |
US |
75 | 2 |
Bone density decreased, Hypoacusis, Asthma, Off label use, |
||||
DUPILUMAB, |
||||
| 579 | 25070553 |
US |
61 | 2 |
Asthma, Wheezing, |
||||
DUPILUMAB, DUPILUMAB, PREDNISONE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, ALPRAZOLAM, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, VALSARTAN, TRIAMTERENE AND HYDROCHLOROTHIAZIDE, AMLODIPINE BESYLATE, MONTELUKAST SODIUM, MONTELUKAST, RISPERIDONE, BUPROPION HYDROCHLORIDE, BUPROPION, OXYGEN, 0XYGEN, BUPROPION HYDROCHLORIDE, MONTELUKAST SODIUM, RISPERIDONE, ALPRAZOLAM, |
||||
| 580 | 25070593 |
US |
1 | |
Asthma, |
||||
DUPILUMAB, |
||||
| 581 | 25070602 |
CA |
51 | 2 |
Asthma, Full blood count abnormal, Bronchiolitis, Carcinoid tumour pulmonary, Disease recurrence, Dyspnoea, Hypoxia, Musculoskeletal discomfort, Oxygen saturation decreased, Peripheral swelling, Productive cough, Sleep disorder due to a general medical condition, Sputum discoloured, Wheezing, Menopausal symptoms, Systemic lupus erythematosus, Loss of personal independence in daily activities, Diarrhoea, Therapeutic product effect incomplete, |
||||
ALENDRONATE SODIUM, DULOXETINE HYDROCHLORIDE, HYDROXYCHLOROQUINE SULFATE, AZATHIOPRINE, LANREOTIDE ACETATE, PREGABALIN, HYDROXYCHLOROQUINE SULFATE, PREDNISONE, ALBUTEROL SULFATE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, TELMISARTAN, MEPOLIZUMAB, |
||||
| 582 | 25070686 |
US |
50 | 1 |
Fatigue, Dyspnoea, Asthma, |
||||
DUPILUMAB, |
||||
| 583 | 25070688 |
US |
43 | 2 |
Abdominal pain upper, Gastrooesophageal reflux disease, Nasopharyngitis, Asthma, Pruritus, Eye discharge, Eye pruritus, Sneezing, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 584 | 25070714 |
US |
55 | 2 |
Asthma, Drug ineffective, |
||||
DUPILUMAB, LOSARTAN POTASSIUM, LOSARTAN, MONTELUKAST SODIUM, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 585 | 25070767 |
US |
80 | 2 |
Asthma, Impaired quality of life, |
||||
DUPILUMAB, |
||||
| 586 | 25070818 |
US |
74 | 2 |
Asthma, Visual impairment, |
||||
INSULIN GLARGINE, |
||||
| 587 | 25070836 |
US |
1 | |
Asthma, |
||||
DUPILUMAB, |
||||
| 588 | 25070860 |
US |
55 | 1 |
Influenza, Upper respiratory tract infection, Asthma, |
||||
DUPILUMAB, |
||||
| 589 | 25070992 |
CA |
43 | 2 |
Abdominal pain, Anaemia, Asthma, Benign uterine neoplasm, Blood iron decreased, Blood pressure systolic decreased, Bruxism, COVID-19, Cough, Discomfort, Dizziness, Drug ineffective, Ear pain, Fatigue, Feeling cold, Headache, Heart rate increased, Hypertension, Illness, Incorrect dose administered, Infection, Influenza, Kidney infection, Menstrual disorder, Mucosal discolouration, Nasopharyngitis, Nausea, Oropharyngeal pain, Pain, Pain in jaw, Peripheral swelling, Pneumonia, Productive cough, Pyrexia, Serum ferritin decreased, Sinusitis, Somnolence, Swelling, Temporomandibular pain and dysfunction syndrome, Urinary tract infection, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, CANDESARTAN, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN, MOMETASONE FUROATE, PREDNISONE, MONTELUKAST SODIUM, ALBUTEROL SULFATE, |
||||
| 590 | 25071470 |
US |
||
Asthma, Dyspnoea, Impaired quality of life, Headache, Arthralgia, Drug ineffective, |
||||
BENRALIZUMAB, |
||||
| 591 | 25071519 |
PT |
2 | |
Leukopenia, Post procedural hypothyroidism, Polymyalgia rheumatica, HIV infection, Peptic ulcer, Dry mouth, Tongue discomfort, Mouth injury, Joint stiffness, Pain, Tinnitus, Gastrointestinal disorder, Chronic respiratory disease, Condition aggravated, Paroxysmal extreme pain disorder, Gastritis, Arthralgia, Osteopenia, Chronic obstructive pulmonary disease, Nasal polyps, Rhinitis allergic, Degenerative bone disease, Dyslipidaemia, Weight increased, Asthma, Bundle branch block left, Alopecia, Abnormal dreams, Confusional arousal, Helicobacter infection, Osteoporosis, Gingivitis, Anxiety, Middle insomnia, |
||||
LEVOTHYROXINE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, ROSUVASTATIN, EFAVIRENZ, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, PANTOPRAZOLE, TIOTROPIUM BROMIDE, |
||||
| 592 | 25061316 |
CN |
76 | |
Asthma, |
||||
BUDESONIDE, IPRATROPIUM BROMIDE, ALBUTEROL SULFATE, ALBUTEROL, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 593 | 25061426 |
CA |
60 | 2 |
Asthma, Dyspnoea, Hypertension, Malaise, Middle insomnia, Nasal polyps, Restrictive pulmonary disease, Weight decreased, Wheezing, Product dose omission issue, |
||||
OMALIZUMAB, OMALIZUMAB, |
||||
| 594 | 25061584 |
CA |
25 | 1 |
Anaphylactic shock, Anxiety, Arthralgia, Arthritis, Asthenia, Asthma, Blood pressure systolic increased, Bronchitis, Burnout syndrome, COVID-19, Chest discomfort, Cough, Diarrhoea, Drug hypersensitivity, Drug ineffective, Dust allergy, Dysphonia, Dyspnoea, Eczema, Fatigue, Forced expiratory volume decreased, Hypoaesthesia, Hypoventilation, Incorrect dose administered, Influenza, Localised infection, Lower respiratory tract infection, Malaise, Middle insomnia, Motor dysfunction, Nasal congestion, Nasopharyngitis, Nausea, Obstructive airways disorder, Oral infection, Oropharyngeal pain, Pain, Pharyngeal swelling, Pyrexia, Rhinorrhoea, Sneezing, Tympanic membrane perforation, Vertebral foraminal stenosis, Vomiting, Weight decreased, Weight increased, Wheezing, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ACLIDINIUM BROMIDE, BUDESONIDE, PREDNISONE, PREDNISONE, PREDNISONE, MONTELUKAST SODIUM, ALBUTEROL SULFATE, |
||||
| 595 | 25061884 |
CA |
65 | 2 |
Asthma, Conjunctivitis, Eustachian tube dysfunction, Obstructive airways disorder, Rhinitis allergic, Sinusitis, |
||||
OMALIZUMAB, |
||||
| 596 | 25061937 |
CA |
58 | 2 |
Aphonia, Arthralgia, Asthma, Body temperature decreased, Chest discomfort, Conjunctivitis allergic, Cough, Diabetes mellitus, Dyspnoea, Feeling hot, Headache, Hypoventilation, Illness, Injection site reaction, Lower respiratory tract infection, Lung disorder, Myalgia, Nasal congestion, Pain, Perfume sensitivity, Productive cough, Pyrexia, Respiratory tract congestion, Rhinitis, Rhinorrhoea, Seasonal allergy, Smoke sensitivity, Spinal fracture, Upper respiratory tract infection, Wheezing, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, PREDNISONE, MONTELUKAST SODIUM, |
||||
| 597 | 25062098 |
CA |
52 | 2 |
Asthma, Breast cancer, Breath sounds abnormal, Bronchial obstruction, COVID-19, Chest pain, Cough, Dyspnoea, Fall, Gastrooesophageal reflux disease, General physical health deterioration, Nasal congestion, Nasopharyngitis, Obesity, Open fracture, Productive cough, Sputum discoloured, Upper respiratory tract infection, Weight decreased, Wheezing, Wrist fracture, Wrong technique in product usage process, Off label use, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE, |
||||
| 598 | 25062139 |
CA |
61 | 1 |
Asthma, Blood pressure systolic increased, Body temperature decreased, Contusion, Cough, Dyspnoea, Dyspnoea exertional, Fatigue, Forced expiratory volume decreased, Injection site bruising, Injection site swelling, Malaise, Middle insomnia, Nasopharyngitis, Obstructive airways disorder, Product dose omission issue, Pulmonary function test decreased, Weight decreased, Weight increased, Wheezing, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, ACLIDINIUM BROMIDE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, CICLESONIDE, AMLODIPINE, AMLODIPINE BESYLATE, RISEDRONATE SODIUM, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 599 | 25062232 |
US |
||
Gallbladder disorder, Food intolerance, Decreased appetite, Ulcer, Vertigo, Atrophy, Asthma, Lacrimation increased, Back pain, Feeling abnormal, |
||||
OSIMERTINIB, |
||||
| 600 | 25062300 |
US |
2 | |
Asthma, |
||||
TIRZEPATIDE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28